Mode
Text Size
Log in / Sign up
N/A N=151 Randomized Single-blind Prevention

Optimal Feeding Tube Dwell Time in VLBW Infants to Reduce Feeding Tube Contamination

Infection

Enrolled (actual)
151
Serious AEs
28.5%
Results posted
Mar 2024
Primary outcome: Primary: Amount of Contamination — 357,000,000; 4,820,000,000 Colony forming units

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Feeding tube dwell time of 48 hours (Device); Feeding tube dwell time of 7 day (Device)
Age
Pediatric · 0+ yrs
Sex
All
Sponsor
University of Florida
Primary completion
Feb 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Amount of Contamination
357,000,000; 4,820,000,000
SECONDARY
Gastrointestinal Inflammation - S100A12
0.87; 0.98
SECONDARY
Gastrointestinal Inflammation - Calprotectin
2.6; 2.6
SECONDARY
Hours of Parenteral Nutrition
195.5; 196.4 0.92
SECONDARY
Days With a Central Venous Line
236.7; 248.3 0.65
SECONDARY
Length of Neonatal Intensive Care Stay
75.6; 75.8 0.96
SECONDARY
Days to Reach Full Feeds
9.3; 9.4 0.77
SECONDARY
Number of Infants With Necrotizing Enterocolitis
4; 6 0.43
SECONDARY
Number of Infants With Late Onset Sepsis
19; 21 0.97
SECONDARY
Episodes of Abdominal Distension
21; 22 0.97
SECONDARY
Number of Infants With a Direct Bilirubin > 2 mg/dL
5; 5 0.79

Summary

The study team will determine whether a decreased feeding tube dwell time will reduce feeding tube contamination

Eligibility Criteria

Inclusion Criteria

  • be born to a mother who is at least 18 years of age and English or Spanish speaking
  • born at < or equal to 30 weeks
  • have a birthweight < or equal to 1500 grams
  • be born to a mother who is COVID Negative
  • have a feeding tube placed within 24 hours of birth
  • be expected to require a feeding tube for 4 weeks following birth.

Exclusion Criteria

  • infant with known congenital GI anomalies
  • infants which are not expected to live
  • infants will be withdrawn from the study if they require abdominal surgery for GI morbidities
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03728608). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search